Home » Newsletters » BioWorld Science

BioWorld Science

March 30, 2011

View Archived Issues

Nicardipine shows promise in study in subjects with Peyronie's disease / News in Context

Immune surrogate response predicts clinical efficacy for TroVax

TPP Global Development and University of Aberdeen enter into drug development agreement

MP-29-02 associated with significant improvements in symptoms of allergic rhinitis

IMD-0354 exhibits proapoptotic effects in CLL cells in vitro by targeting NF-kappa-B

BMS-520 identified as a potent and selective S1P1 receptor agonist

Pfizer targets IRAK-4 for autoimmune diseases

Roche prepares novel compounds that inhibit beta-secretase for diabetes

New azacyclic HSL inhibitors claimed by Roche for diabetes and related disorders

Mallinckrodt reports novel method for monitoring leukemia

Novel dopamine D3 receptor ligands designed at Pierre Fabre

The University of Manchester presents novel kinase inhibitors

Yuma Therapeutics gets grant to develop new therapeutics for Alzheimer's disease

Vertex reports results from ongoing phase III ENVISION study in cystic fibrosis

Adeona Pharmaceuticals receives additional grant for ongoing multiple sclerosis trial

MediGene's Veregen for the treatment of genital warts approved in Spain

CryoLife to expand cardiac surgery portfolio with acquisition of Cardiogenesis

FDA grants 510(k) clearance to BD Diagnostics for fully automated HSV assays

Eisai and Minophagen complete Japanese license agreement for CTCL treatment bexarotene

Toyama Chemical submits application in Japan for influenza treatment T-705

Takeda and Dainippon Sumitomo Pharma enter exclusive Japanese license agreement for ceftaroline

Astellas and Pfizer submit supplemental NDA in Japan to expand approval for Celecox

Bavarian Nordic files application with Health Canada for smallpox vaccine candidate Imvamune

Bionomics reports encouraging results from phase Ib trials of antianxiety candidate BNC-210

Seikagaku withdraws PMA for additional indication of Supartz in U.S.

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 4, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 4, 2025.
First phase of synthetic human genome project successfully completes
BioWorld
The first phase of the U.K. synthetic human genome project has successfully completed, realizing key steps in chromosome synthesis. The work has demonstrated a...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Laigo raises €11.5M seed money for targeted protein degradation
BioWorld Science
Laigo Bio BV has raised €11.5 million (US$13.7 million) in a seed round for the further development of a new approach to inducing targeted protein degradation by...